A multilevel approach for assessing the variability of hepatitis C prevalence in injection drug users by their gathering places

There was heterogeneity in HCV antibody prevalence in IDUs by gathering place, while the influence of injection behaviors varied, suggesting interactivity between factors at the individual and group levels.